Taysha Gene Therapies had a revenue of 2.30M in the quarter ending Mar 31, 2025, with 13.85%. This bring the company's revenue in the last twelve months to 7.22M, Increased -13.31%. In the fiscal year ending Dec 31, 2024, Taysha Gene Therapies had annual revenue of 8.33M with -46.07% growth.